Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents

Am J Cardiol. 2004 Jun 1;93(11):1397-401, A9. doi: 10.1016/j.amjcard.2004.02.039.

Abstract

We evaluated predictors of increased periprocedural creatine kinase-MB isoenzyme levels after implantation of sirolimus-eluting stents with an intent to fully cover the diseased segment. The total stent length per patient (predisposing factor) and elective use of glycoprotein IIb/IIIa (protective factor) were independent predictors of increased creatine kinase-MB isoenzyme levels.

MeSH terms

  • Angioplasty, Balloon, Coronary*
  • Coronary Restenosis / prevention & control
  • Coronary Stenosis / metabolism
  • Coronary Stenosis / therapy*
  • Creatine Kinase / metabolism*
  • Creatine Kinase, MB Form
  • Databases, Factual / statistics & numerical data
  • Equipment Design
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Isoenzymes / metabolism*
  • Linear Models
  • Male
  • Middle Aged
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / therapy
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Sirolimus / administration & dosage*
  • Stents*
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Isoenzymes
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Creatine Kinase
  • Creatine Kinase, MB Form
  • Sirolimus